Landmacy Seeks to Expand Growth Amid Rising Demand for Vegan Supplements
NANTOU, Taiwan, Nov. 16, 2022 /PRNewswire/ -- Landmacy Healthcare Tech Company, the Taiwan-based herbal expert for vegan nutraceutical and nutritional supplements whose name combines "land" and "pharmacy," announced that it is seeking opportunities to expand its business to the wider international market, focusing on the US. The company specializes in 100% plant-based, non-GMO, and cruelty-free supplements and holistic remedies....
BDT Capital Partners acquires minority stake in Exyte
Partnership will enhance Exyte's long-term strategy as the world leader in the design, engineering, and delivery of high-tech facilities Exyte serves clients in the sophisticated markets of semiconductors, battery cells, pharmaceuticals, biotechnology, and data centers; industries offering secular long-term growth Exyte confirms it is successfully on its "Pathway to Ten", targeting...
Lunit to Supply AI Platform to Australia’s BreastScreen NSW Machine Reading Project
Lunit's INSIGHT MMG solution has been selected for mammogram screening in Australia's BreastScreen NSW's AI evaluation and clinical integration project Successful completion of project to be followed by 5-year operation contract with BSNSW to assist radiologists in examining 350,000 women per year SEOUL, South Korea, Nov. 16, 2022 /PRNewswire/ --...
Gracell Biotechnologies Wins 2022 Fierce Life Sciences Innovation Award
FasTCAR next-day manufacturing autologous CAR-T platform recognized with prestigious biotech innovation award SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, Nov. 16, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the...
BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021
VANCOUVER, BC, Nov. 16, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce that interim results from its ongoing preclinical of BVX-1021, the Company's vaccine for SARS-CoV-1 ("SARS1") which is being evaluated in a collaboration with The Ohio State University ("Ohio State") to...
Imaging Endpoints Announces the Appointment of Joy (Huan) Zhu, M.D., Ph.D., as Vice President, Medical Operations
SCOTTSDALE, Ariz., Nov. 16, 2022 /PRNewswire/ -- Imaging Endpoints (IE), the world's largest oncology-focused imaging CRO, announced today the addition of Joy (Huan) Zhu, M.D., Ph.D., to the company as Vice President, Medical Operations. Prior to joining IE, Joy spent 25 years in oncology clinical development. She has held numerous executive positions...
Concord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD Anderson
BEIJING, Nov. 16, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced the successful holding of the Second Annual Academic...
MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System
MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of five required PMA modules needed for FDA approval ST. LOUIS, Nov. 16, 2022 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its commercial partnership...
Xiantao Zhengxin Group Introduces a Fully Automated Mask Production Line to Expand Production Capacity, Reduce Pollution and Contribute to Sustainable Development
Xiantao Zhengxin Group triples production capacity with its fully automated mask production machines XIANTAO, China, Nov. 16, 2022 /PRNewswire/ -- Zhengxin Group (Zhengxin) is proud to introduce its new fully automatic mask production line to expand mask production capacity and start production in November. This production line triples Zhengxin's daily output of masks. In addition, the automatic production line...
YS Biopharma Received Qualified Person Declaration for Its PIKA COVID-19 Vaccine Facility from European Union GMP
GAITHERSBURG, Maryland, Nov. 16, 2022 /PRNewswire/ -- YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics, today announced that its manufacturing facility for PIKA recombinant COVID-19 vaccine successfully passed an audit by a European Union ("EU")...
